INSYS Therapeutics, Inc. (INSY) Reaches $4.72 After 4.00% Down Move; Ardsley Advisory Partners Upped Its Adobe (ADBE) Position

The stock of INSYS Therapeutics, Inc. (NASDAQ:INSY) is a huge mover today! The stock decreased 16.90% or $0.96 during the last trading session, reaching $4.72. About 1.77 million shares traded or 76.43% up from the average. INSYS Therapeutics, Inc. (NASDAQ:INSY) has declined 13.00% since March 13, 2018 and is downtrending. It has underperformed by 17.37% the SP500. Some Historical INSY News: 19/04/2018 – Epilepsy Foundation Testifies Before FDA Advisory Committee in Support of Potential First-Ever Cannabidiol Drug to Treat Dravet; 19/03/2018 – INSYS Therapeutics Reiterates Commitment to Compliant and Ethical Business Practices and Advancing Innovative Product Pipeline; 08/05/2018 – INSYS 1Q ADJ EPS 19C, EST. LOSS/SHR 17C; 08/05/2018 – Insys Therapeutics 1Q Loss/Shr 28c; 26/04/2018 – INSYS Therapeutics and University of California (UC) San Diego Center for Medicinal Cannabis Research to Collaborate on Clinical Trial; 19/04/2018 – GW PHARMACEUTICALS PLC – PDUFA GOAL DATE FOR COMPLETION OF NDA REVIEW OF

... read more at: